Bringing the Oncology Community Together

Janet Hampton on the Distress Thermometer Study Results

Janet Hampton, RN, BS
Published Online: Tuesday, May 24, 2011
Janet Hampton, RN, BS, OCN® from the University of Michigan Health System Cancer Center Explains Distress Thermometer Study Results
Related Articles
New Drug Development Needed in Pancreatic Cancer
In the final segment of the discussion, moderator Johanna Bendell, MD, asks panelists for their thoughts on the management of metastatic pancreatic cancer.
Case Study: Treatment of Metastatic Pancreatic Cancer
Panelists discuss the optimal treatment strategy for a 60 year-old women with a good performance status who presents with a mass in the uncinate process of the pancreas and three liver metastases.
Aduro BioTech Immunotherapy Duo Shows Promise in Pancreatic Cancer
The use of immunotherapy for pancreatic cancer has had limited exposure, but Aduro BioTech, Inc, has had phase II success with an approach in which two vaccines are administered. The vaccines, GVAX Pancreas and CRS-207, are administered to patients sequentially.
Most Popular Right Now
More Reading
External Resources

American Journal of Managed Care
HCPLive
PainLive
Pharmacy Times
Physicians' Education Resource
Physician's Money Digest
Specialty Pharmacy Times
TargetedOnc
OncLive Resources

Archives
Blogs
OncLive TV
Oncology Nurses
Publications
Specialties
Web Exclusives


About Us
Advertise
Advisory Board
Contact Us
Forgot Password
Privacy Policy
Terms & Conditions
Intellisphere, LLC
666 Plainsboro Road
Building 300
Plainsboro, NJ 08536
P: 609-716-7777
F: 609-716-4747

Copyright OncLive 2006-2014
Intellisphere, LLC. All Rights Reserved.